News AZ sells rights to three older drugs to Covis for $350m AstraZeneca has agreed to sell rights to three older drugs for asthma and rhinitis to Covis Pharma for at least $350 million.
News Janssen's RA candidate among hot topics at EULAR But attendees warned to expect "oceanic" weather.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
